HORIZON THERAPEUTICS USA, INC.
Biopharmaceutical manufacturer of a drug product for thyroid eye disease.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 9 of its records are shown together here.
These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination 1st Quarter 2024
|
THORN RUN PARTNERS | $40,000 reported |
|
1st Quarter - Reportreplaced 1st Quarter 2024
|
THORN RUN PARTNERS | $40,000 reported |
|
1st Quarter - Termination 1st Quarter 2024
|
RICCHETTI INCORPORATED | $80,000 reported |
|
1st Quarter - Termination (No Activity) 1st Quarter 2024
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | $40,000 reported |
|
4th Quarter - Termination 4th Quarter 2023
|
TODD STRATEGY GROUP | $50,000 reported |
|
4th Quarter - Reportreplaced 4th Quarter 2023
|
TODD STRATEGY GROUP | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2023
|
THORN RUN PARTNERS | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2023
|
RICCHETTI INCORPORATED | $80,000 reported |
|
4th Quarter - Termination (No Activity) 4th Quarter 2023
|
THE MCMANUS GROUP | $60,000 reported |
|
4th Quarter - Termination 4th Quarter 2023
|
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) | $50,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) In-house | 33 | $36,730,000 |
| COVINGTON & BURLING LLP | 28 | $1,920,000 |
| THE MCMANUS GROUP | 26 | $1,450,000 |
| JEFFREY J. KIMBELL & ASSOCIATES, INC. | 34 | $1,370,000 |
| FOLEY HOAG LLP | 40 | $1,190,000 |
| RICCHETTI INCORPORATED | 15 | $1,170,000 |
| THORN RUN PARTNERS | 21 | $1,160,000 |
| FORBES-TATE | 16 | $950,000 |
| TODD STRATEGY GROUP | 4 | $200,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 172 |
| Medicare/Medicaid | MMM | 136 |
| Taxation/Internal Revenue Code | TAX | 56 |
| Pharmacy | PHA | 18 |
| Budget/Appropriations | BUD | 4 |
| Medical/Disease Research/Clinical Labs | MED | 4 |
| Copyright/Patent/Trademark | CPT | 3 |
| Labor Issues/Antitrust/Workplace | LBR | 2 |
| Small Business | SMB | 1 |
| Government Issues | GOV | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 5376 | 117th | 14 |
| H.R. 2163 | 117th | 11 |
| H.R. 6 | 114th | 8 |
| H.R. 5376 | 118th | 7 |
| H.R. 3 | 116th | 7 |
| H.R. 5260 | 117th | 6 |
| H.R. 2630 | 118th | 5 |
| H.Res. 242 | 116th | 5 |
| H.R. 2113 | 116th | 5 |
| H.R. 19 | 116th | 5 |
| H.R. 4710 | 115th | 5 |
| H.R. 830 | 118th | 4 |
| H.R. 3173 | 118th | 4 |
| H.R. 1425 | 117th | 4 |
| S. 464 | 117th | 4 |
| S.Con.Res. 14 | 117th | 4 |
| H.R. 6963 | 117th | 4 |
| H.R. 1425 | 116th | 4 |
| H.R. 2296 | 116th | 4 |
| S. 2543 | 116th | 4 |
| H.R. 1503 | 116th | 4 |
| H.R. 1 | 115th | 4 |
| H.R. 1628 | 115th | 4 |
| H.R. 2620 | 118th | 3 |
| S. 652 | 118th | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.